SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001860782-25-000004
Filing Date
2025-01-10
Accepted
2025-01-10 16:35:41
Documents
13
Period of Report
2025-01-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K tvst-20250106.htm   iXBRL 8-K 25557
  Complete submission text file 0001860782-25-000004.txt   153684

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tvst-20250106.xsd EX-101.SCH 1891
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tvst-20250106_lab.xml EX-101.LAB 22530
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tvst-20250106_pre.xml EX-101.PRE 13144
16 EXTRACTED XBRL INSTANCE DOCUMENT tvst-20250106_htm.xml XML 2808
Mailing Address 60 BINNEY STREET CAMBRIDGE MA 02210
Business Address 60 BINNEY STREET CAMBRIDGE MA 02210 339-499-9300
2seventy bio, Inc. (Filer) CIK: 0001860782 (see all company filings)

IRS No.: 863658454 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40791 | Film No.: 25523507
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)